What is COLL's Value Score?

Collegium Pharmaceutical, Inc. - Common Stock (COLL) has a StockPik Value Score of 80 out of 100 — a high score, indicating strong value characteristics across multiple metrics. The Value Score is a composite ranking built from P/E ratio, P/B ratio, Graham Number, ROE, gross margin, debt-to-equity, current ratio, and Piotroski F-Score, calculated from SEC EDGAR annual filing data.

What is COLL's Piotroski F-Score?

Collegium Pharmaceutical, Inc. - Common Stock (COLL) has a Piotroski F-Score of 5 out of 9 — a moderate score. The F-Score assesses nine binary financial criteria across profitability, leverage, and operating efficiency. A score of 7–9 indicates a financially improving company; a score of 0–3 is a warning sign.

Is COLL trading below its Graham Number?

COLL is currently trading above its Graham Number. The stock price of $33.25 exceeds the Graham Number of $20.57, meaning it does not meet Graham's criterion for a margin of safety at the current price. The Graham Number is calculated as √(22.5 × EPS × Book Value Per Share) and represents Benjamin Graham's ceiling price for a defensive investor.

What is COLL's Graham Number?

COLL's Graham Number is $20.57, calculated using the Benjamin Graham formula √(22.5 × EPS × Book Value per Share). The Graham Number is an estimate of intrinsic value — the maximum price a defensive investor should pay. At the current price of $33.25, COLL is trading 62% above its Graham Number.

What is COLL's Piotroski F-Score?

COLL's Piotroski F-Score is 5 out of 9, indicating moderate financial health. The Piotroski F-Score evaluates nine criteria across profitability, leverage, and operating efficiency. Scores of 7 or above are considered strong; 3 or below indicate financial weakness.

Is COLL (Collegium Pharmaceutical, Inc. - Common Stock) undervalued?

COLL scores 80/100 on StockPik's Value Score, placing it in undervalued territory. The stock trades 62% above its Graham Number of $20.57.

What is COLL's P/E ratio?

COLL's trailing P/E ratio is 16.8x — a reasonable earnings multiple. The Healthcare sector average P/E is 25.3x. Compare against other Healthcare stocks in the StockPik screener.

What sector is Collegium Pharmaceutical, Inc. - Common Stock (COLL) in?

Collegium Pharmaceutical, Inc. - Common Stock (COLL) is in the Healthcare sector, specifically in the Pharmaceutical Preparations industry. Compare it against other Healthcare stocks by Value Score, P/E ratio, and Piotroski F-Score on StockPik.

Back to Screener

Collegium Pharmaceutical, Inc. - Common Stock (COLL)

NASDAQ Small Cap

Healthcare › Pharmaceutical Preparations

$33.25

Market Cap: $1.1B

Data as of Dec 31, 2025 (TTM)

Price History

Feb 9, 2026 — Mar 26, 2026

Investment Snapshot

Trading 62% above Graham Number — above intrinsic value estimate
Piotroski F-Score 5/9 — moderate financial health
ROE of 20.8% — good return on equity
Revenue growing at 24% annually

Collegium Pharmaceutical, Inc. - Common Stock (COLL) is a Healthcare company operating in Pharmaceutical Preparations, listed on the NASDAQ , with a market capitalisation of $1.1 billion . Key value metrics: P/E ratio 16.8, P/B ratio 3.50, Piotroski F-Score 5 out of 9 (moderate financial health) .

Value Score

out of 100

Try PRO Free — See Full Breakdown

Key Metrics

P/E Ratio

16.79

P/B Ratio

3.50

EPS

$1.98

Div. Yield

—

PEG Ratio

—

P/S Ratio

—

EV/EBITDA

—

ROE

—

ROA

—

Gross Margin

—

Op. Margin

—

Net Margin

—

Debt/Equity

—

Current Ratio

—

Unlock 19 More Metrics — 7 Days Free

Current vs 5-Year Average

Based on 5 years of SEC filings

Net Margin

—

↑ +2.1pp avg —

Gross Margin

—

↑ +2.1pp avg —

Operating Margin

—

↑ +2.1pp avg —

Return on Equity

—

↑ +2.1pp avg —

Debt / Equity

—

↑ +2.1pp avg —

See How Margins & ROE Have Trended — Try PRO

Revenue & Net Income

Profit Margins

Track Gross, Operating & Net Margins — Try PRO

EPS & Free Cash Flow Per Share

See EPS & Free Cash Flow Trends — Try PRO

Financial Statements

Metric	FY22	FY23	FY24
Revenue	$X.XB	$X.XB	$X.XB
Gross Profit	$X.XB	$X.XB	$X.XB
Operating Income	$X.XB	$X.XB	$X.XB
Net Income	$X.XB	$X.XB	$X.XB
EBITDA	$X.XB	$X.XB	$X.XB
Total Assets	$X.XB	$X.XB	$X.XB
Total Liabilities	$X.XB	$X.XB	$X.XB

Unlock 5 Years of Financials — Start Free Trial

Data sourced from SEC EDGAR and Polygon.io. Methodology. View more Healthcare stocks →

Collegium Pharmaceutical, Inc. - Common Stock — Fundamental Analysis Summary

Collegium Pharmaceutical, Inc. - Common Stock (COLL) is currently trading 62% above its Graham Number of $20.57, suggesting the market price exceeds Benjamin Graham's intrinsic value estimate. The stock carries a reasonable trailing P/E ratio of 16.8x.

On financial health, COLL shows a moderate Piotroski F-Score of 5/9, and strong return on equity of 20.8% (sector average: -19.8%), and high leverage with a debt-to-equity ratio of 4.49.

StockPik's composite Value Score for COLL is 80/100 — placing it in undervalued territory. The score is built from ten fundamental signals: P/E, P/B, PEG ratio, P/S ratio, return on equity, gross margin, debt-to-equity, current ratio, dividend yield, and Piotroski F-Score.

COLL reports a solid gross margin of 59.3% (sector average: 33.5%) and a strong operating margin of 23.0%.

COLL shows revenue growing at 24% year-over-year, with earnings declining at 9%.

Top Value Stocks in Healthcare

Symbol	Name	Price	P/E	Score
CYRX	CryoPort, Inc. - Common Stock	$8.21	4.7	100
CRMD	CorMedix Inc. - Common Stock	$6.70	3.6	100
CGEN	Compugen Ltd. - Ordinary Shares	$2.06	5.5	100
ABEO	ABEONA THERAPEUTICS INC.	$4.82	4.5	100
BDMD	Baird Medical Investment Holdings Ltd - Ordinary Share	$2.01	5.8	100

Browse all Healthcare value stocks →

How is the Value Score calculated?

Read our full methodology →

How is the Graham Number calculated?

Benjamin Graham's intrinsic value formula, worked examples, and how to use it →

COLD — AMERICOLD REALTY TRUST, INC.

Columbia Sportswear Company - Common Stock — COLM